Cancer Genetics and Epigenetics

Publisher

1 Aims and Scope

The CGE Journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention research papers describing original researches and reviews of broad general interest in Cancer - a particular emphasis is placed on Molecular Genetics and Epigenetics.

 

The journal encourages and publishes articles that report novel findings of wide biological significance in the areas of:

 

 

The CGE Journal has a fair and transparent process to rapidly publish important science.

2 Copyright

The authors permanently reserve the copyright for their publications and have granted the rights to any third party in advance for using, reproducing or disseminating the work under the terms of copyright and license of the MedSci Publisher’s constitutions and adopted law and regulations.

3 Manuscripts Submission

3.1 Online submission

Manuscripts must be submitted to Cancer Genetics and Epigenetics (CGE) electronically by MedSci Publisher's online submission system. In cases that online submission system is not available, you can submit your manuscript to the submission email of Cancer Genetics and Epigenetics (CGE): edit@cge.medscipublisher.com. If both of the above ways do not work out, you can directly send your manuscripts to the Publishing Manager by yucuianna@sophiapublisher.ca. The editors will handle your submission within five working days.

Preferred file formats of manuscripts are Microsoft Word and Rich Text Format (RTF). Figures, tables, movies, and raw data can be submitted as supplementally files.

A cover letter must be submitted along with the manuscript during the submission, which should contain a brief explanation of what was previously known, the conceptual advance provided by the findings, and the importance of the findings to a broad readership, as well as how and why their major findings relate to the scope of the journal. Closely related papers submitted elsewhere or in press should be noted in the cover letter and uploaded as additional supplementally files in the online submission system. The cover letter is confidential to the editor and will not be seen by reviewers.

3.2 Corresponding Author

The full name, the contact information, and e-mail address of the corresponding author should be provided. We take the corresponding author as the responsible author, which means that the corresponding author accepts such a responsibility: The corresponding author must warrant that all co-authors have read and approved the authorship of the manuscript, the content of the paper, and its submission to CGE. Official approval of all original authors must be provided before any changes in authorship. All reasonable demands on the necessary materials and methods which can justify the experimental results must be satisfied. Please inform the editorial office if the contact information of the corresponding author changes after submission.

4 Article processing

Scientists all over the world are invited to be as peer reviewers for this journal. All submission will be automatically transferred online to the reviewers by Manuscript Proceeding System in the MedSci Publisher prior to CrossRef’s plagiarism check. (see MedSci Publisher peer review policy for further information)

Cancer Genetics and Epigenetics (CGE) offers a fast publication schedule whilst maintaining rigorous peer review. Normally the publication period is two or four weeks depend on the speed of peer review. Using the recommended manuscript preparation formats will largely speed up the paper procedures and shorten the periods. Research articles will be published electronically in provisional PDF immediately upon acceptance. A fully structured web version and PDF download version will be uploaded within four weeks after acceptance.

Cancer Genetics and Epigenetics (CGE) is affiliated with other medsci journals published by MedSci Publisher, including Journal of Vaccine Research, International Journal of Molecular Medical Science and Journal of Vaccine Research. If referees judge that a manuscript is sound but not of special interest and therefore not appropriate for Cancer Genetics and Epigenetics (CGE), the referee reports can be shared with other journals published by MedSci Publisher. Transferring a manuscript from one journal to another will not incur delays. Conversely, if a manuscript submitted to a sister journal in the MedSci Publisher series is judged to be of exceptional interest by the referees and editors. We may offer publication in Cancer Genetics and Epigenetics (CGE).

5 Article-processing charges

All journals under MedSci Publisher do not require article processing charges (APCs) and offer free publication and free access. However, Open access publications are not without costs. As a publisher, MedSci Publisher needs to pay platform operation fees to publishing platform operators. These fees are used for server rentals, journal publishing systems, publishing databases, access space, software upgrades, and the daily operation and maintenance of the journal publishing system. In order to promote the prosperity and development of open access journals, we encourage research institutions, researchers, and authors publishing in MedSci Publisher journals to make voluntary donations. We appreciate your support for the open access publishing model.

Sponsors

1 Organization of the paper

Most research articles published in Cancer Genetics and Epigenetics (CGE) are organized into the following sections: Title page (Title and byline, Author(s) and affiliation(s), Abstract, Keywords, Introduction of the corresponding author), Background, Results, Discussion, Materials and Methods, Authors’ contributions, Acknowledgments, References, Figure Legends, and Tables. Manuscripts should be easy to read and their contents presented clearly, with line number and page number. Figures and Tables should be put at the end of Text (or listed as Supplementary File), each page for one Figure/Table. Click HERE to download a standard manuscript preparation.

1.1 Title and byline

A title gives the reader a clear idea of what the article is about. It should be brief, novel and informative, which could invite readers’ interest. The usual limit for title is less than 25 words. Abbreviations and acronyms, including those for gene and protein names, should be avoided in titles. Common names are allowed for major model systems (maize, rice, yeast). Latin names should be used for all organisms that have no widely accepted common name.

1.2 Author(s) and affiliation(s)

Authorship should be limited to those who have contributed substantially to the work. Please note the corresponding authors and their e-mails. Authors’ given names should be shortened to initials followed by a dot between characters. The authors’ institution should be written below their names.

1.2 Author(s) and affiliation(s)

Authorship should be limited to those who have contributed substantially to the work. Please note the corresponding authors and their e-mails. Authors’ given names should be shortened to initials followed by a dot between characters. The authors’ institution should be written below their names.

1.3 Abstract

The abstract should summarize for a broad audience the main information, including the question being addressed, the approach taken, and the major findings and their significance. It should also be concise (approximately 200~250 words) and independent. General background should be reserved for the introduction. Avoid using too professional words, special symbols, and formula. Literature references should not be included.

1.4 Keywords

List 4~6 keywords which can be used for indexing purposes.

1.5 Background

This section should provide the necessary background information for the average reader, the current situation, and research intention. It should be both complete and concise, just like a mini-review. Previous publications that form a basis for the work presented must be cited.

1.6 Results

This section should be divided with subheadings. Footnotes should not be used.

1.7 Discussion

The Discussion focused on the interpretation of the results and place. It should not be redundant with the Results section. This section may contain subheadings. Insecure sentence like “which needs further research” is discouraged in this section.

1.8 Materials and methods

The section, at minimum, should include enough detail for readers to understand the general experimental design and to be able to assess the data presented. Cite previously published procedures in References. Modifications of previously published procedures should be pointed out. Truly new procedures should be described in detail. Animals, plants, pathogens, and insects or pests should present Latin names. A more detailed version of the procedures and details such as oligo sequences, strains, and specifics of how constructs were made can be included in Supplemental Information.

1.9 Authors’ contributions

In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section.

 

An “author” is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.

 

We suggest the following kind of format (please use initials to refer to each author’s contribution): AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

1.10 Acknowledgments

Acknowledgments of people, grants, funds, etc. should be placed in a separate section before the reference list. The names of funding organizations should be written in full. Please check this section carefully before publication, as amendments or corrections are not allowed after publication.

1.11 References

Only papers that are published or in press papers should be cited in the reference list. Personal communications should be cited within the text only. Submitted articles should be cited as unpublished data, data not shown, or personal communication. All authors should be named in the citation. Provide inclusive page ranges for journal articles and book chapters.

2 Formats

2.1 Heading

Number the first level headings as follows: Results: “1”, Discussion: “2”, Materials and methods: “3”; Mark the second level headings with 1.1, 1.2......, and the third level headings with 1.1.1, 1.1.2......; Lower level headings should be avoided. Acknowledgements and references are not numbered.

2.2 Terminology

Please use the standard mathematical notation for formulae, symbols etc. Genus and species names should be in italics. Use internationally accepted signs and symbols for units, SI units, [e.g., s (seconds), min (minute), h (hour).d (day), m (meter), m2(square meter), Hm2 (hectre), L (liter), g (gram), kg (kilogram), mol (morgan), J (joule) for energy, work, and calories, ×g or r/min for centrifugal force, mol/L for solution concentration, pa for pressure, cM for inheritance distance, kd for molecular weight, kb or bp for DNA fragment length]. Dots are used to separate composite units, e.g., mol?dm-2?m-1.

2.3 Abbreviations

Define abbreviations and acronyms the first time they are used in the main text. Very common abbreviations such as JAFM and SI do not have to be defined. Abbreviations that incorporate periods should not have spaces: write “P.R.,” not “P. R.” Delete periods between initials if the abbreviation has three or more initials; e.g., U.N. but ESA. Do not use abbreviations in the title unless they are unavoidable.

2.4 Tables

All tables are to be numbered using Arabic numerals. Tables should always be cited in text in consecutive numerical order. For each table, the table title explaining the components of the table is necessary. Table legend, if there is one, are placed beneath the table. Identify any previously published material and/or data by giving the original source in the form of a reference in Table legend.

The *, **, and *** are always used in this order to show statistical significance at the 0.05, 0.01, and 0.001 probability levels, and cannot be used for other notes. Lack of significance is usually indicated by NS. Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and be included in the Table legend.

2.5 Figures

CGE requires electronic figures that are as small and simple as is compatible with clarity. Number figures consecutively according to the order in which they are called out in the text. Figures should be unambiguous and as conceptual as possible and should provide enough information so that the reader can understand them without significant input from the text. Format sequence data preferably to one-column width for shorter sequences and two-column width for longer sequences. Make sure that the fonts in sequences are easily readable. Use the same fonts for all figures. For those figures that contain more than one panel, designate the panels with capital letters (no parentheses and no periods following letters) in the upper left-hand corner of each panel.

Each figure should have its corresponding legend below the figure. Provide a short title for each figure. Figure legends should be concise and should not repeat information presented in the text. Figure panels that are designated with capital letters should have specific subtitles in the legend and should be described separately and completely. Symbols and abbreviations that are used in the figure should be defined in the legend.

2.6 Reference

The Harvard (author, date) system of referencing in the text is used (examples are given below). In the text give the author’s name followed by the year in parentheses: (John, 2000). If there are two authors use ‘and’: (Smith and Jones, 2001). When reference is made to a work by three or more authors, the first name followed by et al. should be used: (MacDonald et al., 2002). If more than one work is cited within parentheses, separate citations using a semi-colon (Friedman 1994; Wang et al. 1997), except in the case where the author of the works is the same. In this case the author’s name should not be repeated, only the years should be divided with a semi-colon (Smith 2000; 2002). In the reference list, references should be listed in alphabetical order.

We recommend authors using EndNote to manage the references, MedSci Publisher provides an output style that supports the formatting of in-text citations and reference list:

EndNote style (2 kB)

1) Journal article

Format: Author’s name, Publication Year, Article title, Journal name, volume (issue): page range

a. Only one author

Jindal, 2013, Metal Reinforced Mandibular Overdenture With Bar Attachment-A Case Report, International Journal of Clinical Case Reports, 3: 66-69

Citation in the text: (Jindal, 2013)

b. Two authors

Wong K.B., and Chan S.A., 2014, A Case Report of Malignant Peripheral Nerve Sheath Tumour (Mpnst) Which Present as an Acute Traumatic Sciatic Neuropathy, International Journal of Clinical Case Reports, 4: 1-4

Citation in the text: (Wong and Chan, 2014)

c. More than two authors

Wong K.B., Chan S.A., and Abid Q., 2013, A Case of a Rare Acquired Inflammatory Arterio-venous Malformation with Spontaneous Resolution, International Journal of Clinical Case Reports, 3: 76-78

Citation in the text: (Wong et al., 2013)

2) Private communications, information and data on the internet: just cite in the text

Format for private communications: (Wu Weiren, 2003, private communications

Format for information and data on the internet: (Lin Gang and He Mei, 2002, www.wenweipo_com. htm) or (http://info.Jstage.jst.go.jp/contents/info/list/eng.html)

3) Book

Format: authors’ names, ed., year published, book name, edition number, publisher, publishing location (country and city), pp. page number

Altman A., and Waisel Y., eds., 1997, Biology of root formation and development, Plenum Press, New York and London, pp.376

Buchanan B.B., Gruissem W., and Jones R.L., eds., Qu L.J., Gu H.Y., Bai S.N., Zhao J.G., and Chen Z.L., trans., 2004, Biochemistry & molecular biology of plants, Science Press, Beijing, China, pp.250-288

4) Symposium or book chapter

Format: Authors’ names, Publication year, Article title, In: Symposium editors name+(ed.), Symposium name, publisher, publishing location (country and city), pp. page number

 

Shoemaker R.C., Polzin K.M., Lorenzen L.L., and Specht J.E., 1996, Molecular genetic mapping of soybean, In: Verma D.P.S., and Shoe maker R.C. (eds.), Soybean: genetics, molecular biology and biotechnology, CIAB International, Wallingford, UK, pp.37-56

 

Zhang Q.F., 2007, Toward the development of green super rice using genomics-based strategies, In: Li Z.K., Fang X.J.(eds.), Proceedings of the 2nd international conference of plant molecular breeding, 23~27, March, Sanya, Hainan, China, pp.3

5) Dissertation

Format: Authors’ names, Publication year, Dissertation title, Thesis for M.S./ Dissertation for Ph.D., Affiliation, Supervisor, pp. page number

Jiang L.R., 2004, Improvement of appearance traits of elite rice Zhenshan 97B by molecular introgression of targeted about 800 kb interval from indica rice Jia-fuzhan genome, Thesis for M.S., Life Science and Technology Institute, Guangxi University, Supervisor: Fang X.J., pp.453-454

Wan Y.S., 2002, Construction of soybean genetic map and QTL analysis of some agronomic traits, Dissertation for Ph.D., Biotechnology Research Institute CAAS, Supervisor: Jia S.R., and Fang X.J., pp.37-39

6) Patent document

Format: Patent Assignee Names, year authorized or open, patent title, patent country, patent / application number

Liu Q.L., Bai S.Y., and Ma Y., 2004, An plant expression vector pBinETR1 of ethylene unsusceptivity and application, China Patent, ZL02126837.1

Holton T.A., 1996, Transgenic plants exhibiting altered flower color and methods for producing same, United States Patent, US006080920A

ISSN: 2369-2995